144 related articles for article (PubMed ID: 25747044)
21. Anti-LRP/LR specific antibody IgG1-iS18 and knock-down of LRP/LR by shRNAs rescue cells from Aβ42 induced cytotoxicity.
Da Costa Dias B; Jovanovic K; Gonsalves D; Moodley K; Reusch U; Knackmuss S; Penny C; Weinberg MS; Little M; Weiss SF
Sci Rep; 2013; 3():2702. PubMed ID: 24048171
[TBL] [Abstract][Full Text] [Related]
22. Role of the 37 kDa laminin receptor precursor in the life cycle of prions.
Rieger R; Lasmézas CI; Weiss S
Transfus Clin Biol; 1999 Feb; 6(1):7-16. PubMed ID: 10188208
[TBL] [Abstract][Full Text] [Related]
23. 67kDa laminin receptor regulates the activation of MAPKs through DUSPs in glioma cell line U251.
Jiang L; Zhang C; Wu Y; Jiang Y; Ji Y; Chen F
J BUON; 2015; 20(1):253-60. PubMed ID: 25778325
[TBL] [Abstract][Full Text] [Related]
24. The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein.
Gauczynski S; Peyrin JM; Haïk S; Leucht C; Hundt C; Rieger R; Krasemann S; Deslys JP; Dormont D; Lasmézas CI; Weiss S
EMBO J; 2001 Nov; 20(21):5863-75. PubMed ID: 11689427
[TBL] [Abstract][Full Text] [Related]
25. Recent Advances in the Function of the 67 kDa Laminin Receptor and its Targeting for Personalized Therapy in Cancer.
Pesapane A; Ragno P; Selleri C; Montuori N
Curr Pharm Des; 2017; 23(32):4745-4757. PubMed ID: 28699539
[TBL] [Abstract][Full Text] [Related]
26. Anti-LRP/LR specific antibody IgG1-iS18 impedes adhesion and invasion of liver cancer cells.
Chetty C; Khumalo T; Da Costa Dias B; Reusch U; Knackmuss S; Little M; Weiss SF
PLoS One; 2014; 9(5):e96268. PubMed ID: 24798101
[TBL] [Abstract][Full Text] [Related]
27. Expression and distribution of laminin receptor precursor/laminin receptor in rabbit tissues.
Wang H; Yang L; Kouadir M; Tan R; Wu W; Zou H; Wang J; Khan SH; Li D; Zhou X; Yin X; Wang Y; Zhao D
J Mol Neurosci; 2013 Oct; 51(2):591-601. PubMed ID: 23715696
[TBL] [Abstract][Full Text] [Related]
28. LRP/LR specific antibody IgG1-iS18 impedes neurodegeneration in Alzheimer's disease mice.
Ferreira E; Bignoux MJ; Otgaar TC; Tagliatti N; Jovanovic K; Letsolo BT; Weiss SFT
Oncotarget; 2018 Jun; 9(43):27059-27073. PubMed ID: 29930750
[TBL] [Abstract][Full Text] [Related]
29. Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010 - 2012).
Belluti F; Rampa A; Gobbi S; Bisi A
Expert Opin Ther Pat; 2013 May; 23(5):581-96. PubMed ID: 23425062
[TBL] [Abstract][Full Text] [Related]
30. Biosynthesis of the 67 kDa high affinity laminin receptor.
Castronovo V; Claysmith AP; Barker KT; Cioce V; Krutzsch HC; Sobel ME
Biochem Biophys Res Commun; 1991 May; 177(1):177-83. PubMed ID: 1828340
[TBL] [Abstract][Full Text] [Related]
31. Microinjection of lentiviral vectors expressing small interfering RNAs directed against laminin receptor precursor mRNA prolongs the pre-clinical phase in scrapie-infected mice.
Pflanz H; Vana K; Mitteregger G; Pace C; Messow D; Sedlaczek C; Nikles D; Kretzschmar HA; Weiss SF
J Gen Virol; 2009 Jan; 90(Pt 1):269-74. PubMed ID: 19088298
[TBL] [Abstract][Full Text] [Related]
32. Adhesion and Invasion of Breast and Oesophageal Cancer Cells Are Impeded by Anti-LRP/LR-Specific Antibody IgG1-iS18.
Khumalo T; Reusch U; Knackmuss S; Little M; Veale RB; Weiss SF
PLoS One; 2013; 8(6):e66297. PubMed ID: 23823499
[TBL] [Abstract][Full Text] [Related]
33. Diverse patterns of expression of the 67-kD laminin receptor in human small intestinal mucosa: potential binding sites for prion proteins?
Shmakov AN; Bode J; Kilshaw PJ; Ghosh S
J Pathol; 2000 Jul; 191(3):318-22. PubMed ID: 10878555
[TBL] [Abstract][Full Text] [Related]
34. Anti-LRP/LR specific antibody IgG1-iS18 significantly impedes adhesion and invasion in early and late stage colorectal carcinoma cells.
Vania L; Chetty CJ; Ferreira E; Weiss SFT
Mol Med; 2016 Oct; 22():664-673. PubMed ID: 27611822
[TBL] [Abstract][Full Text] [Related]
35. Reactive microgliosis participates in MPP+-induced dopaminergic neurodegeneration: role of 67 kDa laminin receptor.
Wang T; Zhang W; Pei Z; Block M; Wilson B; Reece JM; Miller DS; Hong JS
FASEB J; 2006 May; 20(7):906-15. PubMed ID: 16675848
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of LRP/LR induces apoptosis in pancreatic cancer and neuroblastoma cells through activation of caspases.
Chetty CJ; Ferreira E; Jovanovic K; Weiss SFT
Exp Cell Res; 2017 Nov; 360(2):264-272. PubMed ID: 28899658
[TBL] [Abstract][Full Text] [Related]
37. siRNA - Mediated LRP/LR knock-down reduces cellular viability of malignant melanoma cells through the activation of apoptotic caspases.
Rebelo TM; Vania L; Ferreira E; Weiss SFT
Exp Cell Res; 2018 Jul; 368(1):1-12. PubMed ID: 29653110
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic approaches targeting the prion receptor LRP/LR.
Zuber C; Ludewigs H; Weiss S
Vet Microbiol; 2007 Aug; 123(4):387-93. PubMed ID: 17498894
[TBL] [Abstract][Full Text] [Related]
39. Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor.
Hundt C; Peyrin JM; Haïk S; Gauczynski S; Leucht C; Rieger R; Riley ML; Deslys JP; Dormont D; Lasmézas CI; Weiss S
EMBO J; 2001 Nov; 20(21):5876-86. PubMed ID: 11689428
[TBL] [Abstract][Full Text] [Related]
40. Knock-down of the 37-kDa/67-kDa laminin receptor in mouse brain by transgenic expression of specific antisense LRP RNA.
Leucht C; Vana K; Renner-Müller I; Dormont D; Lasmézas CI; Wolf E; Weiss S
Transgenic Res; 2004 Feb; 13(1):81-5. PubMed ID: 15070079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
